Torrent Pharma Inc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Torrent Pharma Inc Pharmaceutical Import Records from India — 9 Products, $41.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Torrent Pharma Inc — Pharmaceutical Importer Profile (2026) | 9 Products, $41.5M Trade | TransData Nexus

Torrent Pharma Inc

Pharmaceutical Importer · United States · CNS & Psychiatric Focus · $41.5M Total Trade · DGFT Verified

Torrent Pharma Inc is a pharmaceutical importer based in United States with a total trade value of $41.5M across 9 products in 6 therapeutic categories. Based on 976 verified import shipments from Indian Customs (DGFT) records, Torrent Pharma Inc is the #1 buyer in 3 products including Isosorbide, Dapsone, Sorafenib. Torrent Pharma Inc sources from 3 verified Indian suppliers, with Torrent Pharmaceuticals Limited accounting for 95.9% of imports.

Torrent Pharma Inc — Import Portfolio & Supplier Network

Torrent Pharma Inc import network — 9 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Torrent Pharma Inc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Torrent Pharmaceuticals Limited	$83.8M	3,020	95.9%
Umedica Laboratories Private Limited	$3.4M	123	3.9%
Zenara Pharma Private Limited	$161.9K

What Formulations Does Torrent Pharma Inc Import?

Formulation	Value	Ships
Pantoprazole sodium dr tablets USP 40 MG	$753.5K	22
Isosorbide mononitrate er tablets, USP	$619.9K	31
Other-tolterodine tartrate extended	$611.4K	18
Escitalopram tablets USP 20MG	$590.1K	12
Pantoprazole sodium dr tablets USP 40MG	$562.8K	19
Duloxetine delayed release capsules	$527.5K	24
Other-nystatin cream USP 100000 un/g	$487.0K	14
Other-pantoprazole sodium dr tablets	$456.8K	10
Isosorbide mononitrate er tablets, USP	$451.9K	18
Other - escitalopram tablets USP 20MG (ndc no. 13668-137-10) ( escitalopram 20MG) nos size 1x1000	$450.0K	9
Duloxetine delayed release CAPS USP 60MG	$427.8K	12
Other - nystatin cream USP, 100000 un/g,30g us (ndc 13668-595-02) ( nystatin cream 30g ) nos size	$406.2K	10
Rabeprazole sodium delayed release	$402.5K	11
Rosuvastatin tablets USP 20MG (bottles of 500 tablets)	$395.0K	9
Escitalopram tablets USP 10 MG	$367.4K	9

Torrent Pharma Inc imports 1,774 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 9 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Pantoprazole	Gastrointestinal	$11.2M	244	0.6%	9
2	Citalopram	CNS & Psychiatric	$7.3M	145	2.8%	2
3	Isosorbide	Cardiovascular	$5.6M	154	10.0%	1
4	Rosuvastatin	Cardiovascular	$4.6M	123	1.0%	18
5	Nystatin	Antifungals	$4.5M	143	8.6%	3
6	Escitalopram	CNS & Psychiatric	$4.2M	83	2.1%	2
7	Dapsone	Antimalarial & Antiparasitic	$1.9M	37	5.8%	1
8	Fluoxetine	CNS & Psychiatric	$1.8M	35	0.4%	5
9	Sorafenib	Advanced Oncology	$600.0K	12	2.4%	1

Torrent Pharma Inc imports 9 pharmaceutical products across 6 categories into United States totaling $41.5M. The company is the #1 buyer for 3 products: Isosorbide, Dapsone, Sorafenib.

Torrent Pharma Inc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Torrent Pharma Inc. is a U.S.-based pharmaceutical importer and buyer specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2004, Torrent Pharma Inc. operates as a wholly owned subsidiary of Torrent Pharmaceuticals Ltd., a leading Indian pharmaceutical company with a significant presence in the global generics market. Headquartered in Basking Ridge, New Jersey, Torrent Pharma Inc. plays a pivotal role in the U.S. pharmaceutical distribution network by sourcing a diverse range of generic medications from India to meet the needs of the American market.

Torrent Pharmaceuticals Ltd., the parent company, is renowned for its extensive portfolio across various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, and women's healthcare. The company has a strong global footprint, marketing its products in over 50 countries. Torrent Pharma Inc. leverages this global presence to import and distribute high-quality generic pharmaceuticals, contributing to the accessibility and affordability of essential medications in the United States.

2Distribution Network

Torrent Pharma Inc. maintains a centralized distribution model from its headquarters in Basking Ridge, New Jersey. While specific warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic position in New Jersey provides advantageous access to major U.S. transportation hubs, facilitating efficient distribution across the country. This centralization enables Torrent Pharma Inc. to effectively manage its supply chain and ensure timely delivery of pharmaceutical products to meet market demand.

3Industry Role

In the United States pharmaceutical supply chain, Torrent Pharma Inc. functions primarily as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from India, the company serves as a conduit between Indian manufacturers and the U.S. market, ensuring the availability of generic medications. This role is crucial in enhancing competition, reducing drug costs, and providing patients with access to a broader range of treatment options.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Torrent Pharma Inc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Torrent Pharma Inc. exhibits a high degree of sourcing concentration, with 95.9% of its imports originating from Torrent Pharmaceuticals Ltd. This substantial reliance on a single supplier indicates a strategic choice to maintain consistency in product quality and supply chain reliability. However, such concentration also presents potential risks, including vulnerability to supply disruptions or changes in the supplier's operational capacity. The remaining 4.1% of imports from Umedica Laboratories Private Limited and Zenara Pharma Private Limited suggest a diversification strategy to mitigate these risks and ensure a steady supply of pharmaceutical products.

2Supply Chain Resilience

The resilience of Torrent Pharma Inc.'s supply chain is bolstered by its partnerships with multiple Indian suppliers, including Torrent Pharmaceuticals Ltd., Umedica Laboratories Private Limited, and Zenara Pharma Private Limited. This diversification allows the company to mitigate potential disruptions from any single supplier. Additionally, Torrent Pharmaceuticals Ltd.'s extensive global presence and robust manufacturing capabilities enhance the overall stability and reliability of the supply chain. While specific details regarding backup suppliers, formulation diversity, and shipping routes are not publicly available, the existing supplier network and strategic sourcing practices contribute to a resilient supply chain capable of adapting to market fluctuations and ensuring continuous product availability.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth the legal framework for drug imports, ensuring that all imported drugs meet standards for quality, safety, and effectiveness. For Indian pharmaceutical companies exporting to the U.S., obtaining FDA approval for their drug products is mandatory. This process involves submitting an Abbreviated New Drug Application (ANDA) for generics, demonstrating bioequivalence to the reference listed drug, and complying with Good Manufacturing Practice (GMP) regulations. Additionally, foreign drug establishments must register with the FDA and list all their drug products intended for U.S. distribution.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the U.S. are governed by the FDA. All foreign drug establishments whose products are imported into the United States are required to register their establishment with the FDA and list all of their drug products in commercial distribution in the United States. Regarding Good Manufacturing Practice (GMP), the FDA recognizes GMP certifications from various international standards, including EU GMP, WHO GMP, and PIC/S. Indian pharmaceutical manufacturers seeking to export to the U.S. must ensure their facilities comply with these recognized GMP standards to meet FDA requirements. Additionally, wholesale distribution authorization is required for entities involved in the distribution of pharmaceutical products within the U.S., ensuring that all intermediaries in the supply chain adhere to regulatory standards.

Torrent Pharma Inc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Torrent Pharma Inc.'s focus on importing pharmaceutical products in the therapeutic areas of cardiovascular, central nervous system, and gastrointestinal reflects a strategic alignment with prevalent health concerns in the United States. These areas represent significant segments of the U.S. pharmaceutical market, driven by high patient demand and ongoing medical advancements. By concentrating on these therapeutic categories, Torrent Pharma Inc. aims to address critical health issues and provide patients with access to effective treatment options.

2Sourcing Profile

Torrent Pharma Inc. primarily sources generic drug formulations from India, leveraging the country's robust pharmaceutical manufacturing capabilities and cost advantages. The company's sourcing strategy emphasizes obtaining finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, rather than raw Active Pharmaceutical Ingredients (APIs) or bulk drugs. This approach allows Torrent Pharma Inc. to offer a diverse range of generic medications to the U.S. market, meeting various patient needs and therapeutic requirements.

3Market Positioning

Seller's Guide — How to Become a Supplier to Torrent Pharma Inc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the U.S. market by meeting the stringent regulatory requirements set by the FDA and demonstrating a commitment to quality and reliability. Gaps in Torrent Pharma Inc.'s current sourcing may exist in specific therapeutic areas or product formulations not currently covered. Indian exporters can explore these opportunities by aligning their product offerings with the unmet needs in the U.S. market and ensuring compliance with all regulatory standards.

2Requirements & Qualifications

Indian exporters seeking to supply pharmaceutical products to Torrent Pharma Inc. and the U.S. market must obtain FDA approval for their drug products, which involves submitting an ANDA and complying with recognized GMP standards. Additionally, foreign drug establishments must register with the FDA and list all their drug products intended for U.S. distribution. Ensuring that products meet FDA labeling requirements, including English language labeling and accurate information, is also essential. Maintaining high-quality manufacturing practices and adhering to FDA regulations are critical qualifications for successful entry into the U.S. pharmaceutical market.

How to Approach

Frequently Asked Questions — Torrent Pharma Inc

What products does Torrent Pharma Inc import from India?

Torrent Pharma Inc imports 9 pharmaceutical products across 6 categories. Top imports: Pantoprazole ($11.2M), Citalopram ($7.3M), Isosorbide ($5.6M), Rosuvastatin ($4.6M), Nystatin ($4.5M).

Who supplies pharmaceuticals to Torrent Pharma Inc from India?

Torrent Pharma Inc sources from 3 verified Indian suppliers. The primary supplier is Torrent Pharmaceuticals Limited (95.9% of imports, $83.8M).

What is Torrent Pharma Inc's total pharmaceutical import value?

Torrent Pharma Inc's total pharmaceutical import value from India is $41.5M, based on 976 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Torrent Pharma Inc focus on?

Torrent Pharma Inc imports across 6 categories. The largest: CNS & Psychiatric (31.7%), Gastrointestinal (27.1%), Cardiovascular (24.6%).

Get Full Torrent Pharma Inc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.